donepezil and losartan potassium

donepezil has been researched along with losartan potassium in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Borghgraef, C; Delvaux, N; Etienne, AM; Libert, Y; Razavi, D; Reynaert, C1
Dietrich, J; Karschnia, P; Parsons, MW1

Reviews

2 review(s) available for donepezil and losartan potassium

ArticleYear
[Treatment of cognitive impairments in oncology: a review of longitudinal controlled studies].
    Bulletin du cancer, 2014, Volume: 101, Issue:9

    Topics: Adult; Benzhydryl Compounds; Case-Control Studies; Central Nervous System Stimulants; Cognition; Cognition Disorders; Darbepoetin alfa; Donepezil; Erythropoietin; Estradiol; Executive Function; Female; Humans; Indans; Longitudinal Studies; Male; Meditation; Methylphenidate; Modafinil; Neoplasms; Piperidines

2014
Pharmacologic management of cognitive impairment induced by cancer therapy.
    The Lancet. Oncology, 2019, Volume: 20, Issue:2

    Topics: Antineoplastic Agents; Central Nervous System Stimulants; Cholinesterase Inhibitors; Cognitive Dysfunction; Donepezil; Erythropoietin; Forecasting; Humans; Methylphenidate; Modafinil; Neoplasms; Radiotherapy

2019

Other Studies

1 other study(ies) available for donepezil and losartan potassium

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013